机译:胆囊收缩素受体成像的三种〜(68)Ga-和〜(111)In标签肽段的体外和体内表征
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, the Netherlands,PO Box 9101, 6500 HB, Nijmegen, the Netherlands;
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, the Netherlands;
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, the Netherlands;
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, the Netherlands;
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, the Netherlands;
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, the Netherlands;
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, the Netherlands;
机译:表达尿激酶型纤溶酶原激活物受体(uPAR)的人类癌症体内定位的〜(111)内标签肽的合成与表征
机译:68)Ga和(111)In标记的DOTA-RGD肽用于成像的alphavbeta3整合素表达。
机译:[Tc(N)(PNP)] 2+金属片段标记的胆囊收缩素8(CCK8)肽,用于CCK-2受体成像:体内和体外研究
机译:〜(99m)通过使用氨基膦膦酰基团的CCK8肽的TC标记:体外和胆囊蛋白-B受体成像的体内评价
机译:胃细胞中胆囊收缩素样肽受体的表征。
机译:点击用于分子成像和治疗环化镓-68标记的肽的合成和初步体外和体内评价在黑素瘤模型系统
机译:用于胆囊收缩素受体成像的三种68Ga和111In标记肽的体外和体内表征